BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Diagnosis
571 results:

  • 1. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma.
    Zhang T; Wang ZT; Li Z; Yin SX; Wang X; Chen HZ
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):120. PubMed ID: 38466431
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
    Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
    Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas.
    Chen YB
    Adv Anat Pathol; 2024 Mar; 31(2):118-125. PubMed ID: 38145398
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell lymphoma or Large B-Cell lymphoma?
    Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
    Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Comprehensive diagnosis of Mantle Cell lymphoma].
    Yang H; Guo R; Shi Y; Wang R; Qiao C; Wu YJ; Fan L; Xu W; Li JY; Qiu HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1720-1725. PubMed ID: 38071051
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes.
    Pizzi M; Bongiovanni L; Lorenzi L; Righi S; Scarmozzino F; Balzarini P; Santoro L; Mussolin L; Carraro E; Pillon M; Bonaldi L; Vianello F; Agostinelli C; Ponzoni M; Dei Tos AP; Sabattini E
    Virchows Arch; 2024 Mar; 484(3):521-526. PubMed ID: 37962684
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens.
    Milnerowicz S; Maszewska J; Skowera P; Stelmach M; Lejman M
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958832
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Secondary malignancies among mantle cell lymphoma patients.
    Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
    Eur J Cancer; 2023 Dec; 195():113403. PubMed ID: 37952281
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.
    Minson A; Hamad N; Di Ciaccio P; Talaulikar D; Ku M; Ratnasingam S; Cheah C; Yannakou CK; Bishton M; Ng ZY; Agrawal S; McQuillan A; Johnston A; Choong E; Wong K; McQuillan J; Beekman A; Hawkes E; Dickinson M
    Br J Haematol; 2024 Feb; 204(2):548-554. PubMed ID: 37904342
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.
    Bodet-Milin C; Morvant C; Carlier T; Frecon G; Tournilhac O; Safar V; Kraeber-Bodere F; Le Gouill S; Macintyre E; Bailly C
    Sci Rep; 2023 Oct; 13(1):18177. PubMed ID: 37875524
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Use of CD200 in the Differential diagnosis of B-Cell Lymphoproliferative Disorders.
    Al-Zubaidi HK; Hughes SF
    Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
    [No Abstract]    [Full Text] [Related]  

  • 13. A collision tumor of nasopharyngeal carcinoma and primary mantle cell lymphoma in the nasopharynx: a case report and review of the literature.
    Jiang M; Yuan XP; Zhang H; Li CQ; Mao YL; Chen WL
    BMC Oral Health; 2023 Sep; 23(1):672. PubMed ID: 37718438
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Double hit: Mantle Cell lymphoma associated with squamous cell carcinoma or chalazion? A case report.
    Malvasi M; Florido A; Calandri A; Piro L; Pacella F; Vingolo EM
    Clin Ter; 2023; 174(5):390-394. PubMed ID: 37674447
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and
    Rodrigues JM; Hollander P; Schmidt L; Gkika E; Razmara M; Kumar D; Geisler C; Grønbæk K; Eskelund CW; Räty R; Kolstad A; Sundström C; Glimelius I; Porwit A; Jerkeman M; Ek S
    Haematologica; 2024 Apr; 109(4):1171-1183. PubMed ID: 37646663
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
    Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
    Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Bilateral Lacrimal Gland Mantle Cell lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature.
    Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N
    J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.
    Nikkarinen A; Lokhande L; Amini RM; Jerkeman M; Porwit A; Molin D; Enblad G; Kolstad A; Räty R; Hutchings M; Weibull CE; Hollander P; Ek S; Glimelius I
    Blood Adv; 2023 Sep; 7(18):5304-5313. PubMed ID: 37389827
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Pancreatic Collision Tumor Comprising Mantle Cell lymphoma and Adenocarcinoma: A Case Report and Literature Review.
    Sugaya R; Taniguchi A; Abe M; Ozawa I; Kirito K; Hatakeyama S
    Intern Med; 2024 Feb; 63(4):553-558. PubMed ID: 37380453
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Estimating the Associated Burden of Illness and Healthcare Utilization of Newly Diagnosed Patients Aged ≥65 with Mantle Cell lymphoma (mcl) in Ontario, Canada.
    Anglin P; Elia-Pacitti J; Eberg M; Muratov S; Kukaswadia A; Sharma A; Ewara EM
    Curr Oncol; 2023 Jun; 30(6):5529-5545. PubMed ID: 37366901
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.